SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,852.90 -876.37
( -1.17%)

Global Indices

Nasdaq

52,025.19 -173.50
(-0.33%)

Dow Jones

7,682.22 -82.84
(-1.07%)

Hang Seng

65,031.31 -292.98
(-0.45%)

Nikkei 225

10,765.28 -116.62
(-1.07%)

Forex

USD-INR

94.85 -0.23
(-0.24%)

EUR-INR

106.35 0.11
(0.11%)

GBP-INR

125.73 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532649

INE023H01027

29.975558

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NECLIFE

204.95

EPS(TTM)

Face Value()

Div & Yield %

Back

iconik sports & events ltd

Trent consolidated net profit rises 20.79% in the June 2026 quarter

Aug 06,2026

Net profit of Trent rose 20.79% to Rs 519.01 crore in the quarter ended June 2026 as against Rs 429.69 crore during the previous quarter ended June 2025. Sales rose 17.84% to Rs 5754.71 crore in the quarter ended June 2026 as against Rs 4883.48 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	5754.71	4883.48	18
OPM %	19.45	17.36	-
PBDT	1102.00	857.62	28
PBT	691.84	564.69	23
NP	519.01	429.69	21

73,852.90 -876.37 ( -1.17%)

52,025.19 -173.50 (-0.33%)

7,682.22 -82.84 (-1.07%)

65,031.31 -292.98 (-0.45%)

10,765.28 -116.62 (-1.07%)

94.85 -0.23 (-0.24%)

106.35 0.11 (0.11%)

125.73 -0.01 (-0.01%)

0.60 0.00 (0.07%)